TG Therapeutics – Spearheading Innovations in Lymphoma Treatment
TG Therapeutics (NASDAQ: TGTX), a clinical stage company that is leading the innovation bandwagon in the field of novel therapies for B-cell malignancies and...
TG Therapeutics (NASDAQ: TGTX), a clinical stage company that is leading the innovation bandwagon in the field of novel therapies for B-cell malignancies and...
Gonorrhoea, caused by a bacterial pathogen N. gonorrhoea, is the second most commonly reported sexually transmitted disease in the U.S alone. The data made...
Mustang Bio’s (NASDAQ: MBIO) shares rose by almost 250% after its development partner, St Jude Children’s Research Hospital in Memphis, published study results...
The Muscular Dystrophy Association describes Duchenne Muscular Dystrophy (DMD) as a fatal, X-linked genetic neuromuscular disorder that leads to progressive, irreversible loss of...
Stem Cell Therapy is emerging as the future of therapeutics for numerous diseases and disorders which have hitherto been unaddressed. The growing awareness...
Parkinson’s is the second most common age-related neurodegenerative disorder, characterized by muscle rigidity, bradykinesia, cognitive impairment, etc. An estimated one million people in...
Erectile dysfunction (ED) commonly called impotence is a sexual dysfunction marked by the inability to develop or maintain an erection. ED though not fatal, can severely...
On April 3, 1973 Martin Cooper, an engineer working for Motorola and credited with the invention of cell phone, made the first public...
Breast cancer is the most common form of cancer in women with an estimated one in eight women and one in 1,000 men...